← All Sponsors
SPONSOR

Aerogen Pharma Limited

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Respiratory Distress SyndromePre-term Infants
NCT06776783 Phase 3
Recruiting

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

Respiratory Distress Syndrome
United States View Trial →